We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

March 5, 2021

The Telehealth [R]evolution

Commentary
Ramzy Ross (DrDoctor) | Alette Brinth (HealthXL)
&

The world has undeniably experienced an explosive upward trend in telehealth adoption over the last 12 months, fuelled by a global pandemic. In the US, the CDC reported a 50 % increase in telehealth visits in the first quarter of 2020 alone. Across the pond in the UK, Deloitte recently reported that 80% of healthcare providers increased the adoption of digital technologies to provide virtual support and engage more effectively with patients. A rare opportunity to innovate and reimagine the delivery of medicine has been created in the eye of the storm, and stakeholders across the healthcare industry have been thrust into alignment on a common goal: how do we continue to deliver high-quality patient care in an era of social distancing? 

The fact is, telehealth is so much more than seeing your doctor on a screen - it’s not just an evolution of care-delivery, it’s a revolution! Here are some of the big disruptions happening, and some of the opportunities that await.

Going Green & Going Global: The Social and Environmental Impact of Telehealth

In a world enabled by telemedicine, patients in vulnerable communities have greater access to quality of care that would otherwise be restricted by cost, time and travel considerations. Can telehealth bring us one step closer to bridging the gaps in global health inequality? It is estimated that in developing countries like Malawi, there is only 1 physician available for every 62,500 people - 150X lower than in the US. These gaps can now be addressed by initiatives such as the World Telehealth Initiative partnership with Teladoc to connect physicians with patients in developing countries. A growing network of physicians are volunteering their time, and it is projected that an additional 24-36 million patients could be treated annually if every US physician currently using televisits (estimated at 0.5 million) volunteered just 1 hour a month. 

It goes without saying that a rise in telehealth will significantly reduce the medical industry’s carbon footprint. The green impact of the reduction in travel of patients and healthcare workers is significant, with a swedish study estimating a 40-70 fold reduction in carbon emissions by pivoting from physical to virtual appointments alone. Furthermore, it has also been demonstrated that converting to digital ways of working can not only help healthcare organisations reduce administrative related hours but also contribute to reducing their carbon footprint with reports of up to 70% reductions in paper use for activities such as printed appointment letters.

(Source: DrDoctor)

The Connected Patient: Putting the Patient Center-Stage

There is growing evidence supporting the necessity of increasingly putting patients at the core of evolving, and new, healthcare models. Healthcare governing bodies, providers and health technology organisations, across the globe, are continually evaluating how to enhance patient-centred care. They are increasingly pivoting towards digital opportunities to better incorporate patient profiling, and tailored feedback, with the view to deliver bespoke, patient-centric communications and care management. NHS England is one example of this where they refer to patient centred care planning incorporating personal health budgets and supporting patient preferences.  

The case for change is primarily driven by healthcare supply and demand. One example of increasing demand is outpatient hospital services, which have almost doubled in England over the last 12 years. Currently valued at 120 million a year, this increase in demand for outpatient services in the UK has called for radical change in outpatient care services by esteemed organisations such as the Royal College of Physicians.

Breaking this down further, the evidence often points to follow-up related appointments as being a significant contributor to the increase. To add to the problem, statistics often also show that the proportion of non-attended appointments is also on the rise - inevitably adding to waitlist delays and contributing to poor patient experiences.

In attempts to counter such challenges, digital health technology organisations are continually scoping opportunities to tackle the problem and improve healthcare delivery. One solution that is gaining a lot of interest from HCPs and patients is patient-initiated follow-up, aka PIFU, allowing patients to become more in control of their care including the self-scheduling of appointments. Organisations, such as DrDoctor, believe that PIFU oriented models are key to not only solving challenges such as the patient waitlist backlog (which the current pandemic has only exacerbated), but can go further in terms of making patients feel like responsible partners in their personal care journey and lending to improved patient satisfaction.

Reimagining Medicine: The connected doctor

The increased adoption of video calling by clinicians has undoubtedly helped overcome some of the health and safety challenges associated with the delivery of care - particularly during the Covid-19 pandemic. However, video calling is only one solution that forms part of a wider tool-kit of remote engagement and monitoring capabilities. Innovators are increasingly working to develop both passive (such as wearable technologies) and active tools (such as digital questionnaires or assessments) in view of creating remote models of care that allow patients to be monitored more closely and in the convenience of their own home. Remote patient monitoring solutions are also gaining increasing traction in the marketplace, which were reported to attract an estimated USD $642 million in investments in 2020, up 13 % since 2019.

(Source: HealthXL platform)

From the clinicians’ perspectives, this provides key advantages including enabling clinicians to identify potential patient health deterioration sooner leading to better patient health outcomes. From a healthcare management perspective, this also enables ‘asynchronous capacity’ - in other words - an increase in capacity of clinician availability so more patients can be seen within a given timeframe. Such methods are continually gaining recognition for their abilities to benefit both patients, and healthcare providers alike, and projects such as ‘My Online Care’ are a testament to such developments.

A second opinion: AI real-time decision-support

As healthcare systems struggle to handle overloaded hospitals, clinical decision support systems (CDSS) provide physicians with a way to deliver diagnoses remotely. Astronauts in space have relied on CDSS like VisualDX for years to stay informed on their symptoms in the remotest of settings. NASA’s human research program has actively funded research in CDSS to ensure that even on a space mission to Mars (where the time-delay to a doctor is 20 minutes), astronauts can stay in control of their symptoms and risk factors. Back on Earth, the benefits of AI-powered triaging and CDSS are being felt not only in the physician's office, but also in the emergency room workflow. The Scandinavian startup Corti teamed up with Sweden’s SOS Alarm emergency service to utilize Audia (an audio-based AI platform) to help emergency workers detect out-of-hospital cardiac arrests. The results demonstrated a whopping 50 % reduction in undetected out-of-hospital cardiac arrest cases, a 30 % increase in time saved with call protocols and 25 % faster detection rates.

(Source: Corti)

Medical Device companies are also seeing the benefits of CDSS, and last month Ipsen announced a partnership with Mendelian to speed up rare disease diagnosis by integrating MendelScan software into NHS systems to scan EHR records for symptoms and risk factors. Partnerships like these are paving the way for a preventative care model, where data analytics give doctors a 360° patient view to help more efficiently predict risk and enable early intervention. In a recent survey, PWC reported 74 % of health executives saying their organizations would invest more in predictive modelling in 2021.

Keeping the momentum

The reality is, telehealth experienced two breakthroughs during the pandemic: an uptake in adoption and a permanent place in the overall strategy of healthcare organizations. However, the challenge now is not to lose the momentum that has been gained. The current climate provides a real opportunity to further lay foundations and accelerate progress that, not only, addresses current pressures but is also ready for the future and the exciting new innovations it will undoubtedly reveal.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sustainable Business Models for DTx

16th August @ 10:45AM EDT

It is one of the key questions that every digital therapeutic (DTx) company must answer - what business model will set them up for success in the long run? Join this meeting to discuss this further and share your experiences with your peers working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Payers Partnerships for DTx

17th August @ 10:45AM EDT

Digital Therapeutics (DTx) vendors face many challenges on their journey to commercialization, such as generating clinical data, health economics evidence and achieving regulatory status. Join this meeting to discuss this topic further and share your experiences with others working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: How to Overcome the Blockers to DTx Adoption and Measure Success? (Part 2)

25th August @ 10:45AM EDT

While new legislations and rules (such as DiGA in Germany) have opened new options for reimbursement, adoption of digital therapeutics (DTx) remains insufficient to achieve the revenue expected from these solutions. Join this 2 part sprint to discuss this topic further.

Featuring
Mette Dyhrberg
Mette Dyhrberg
Founder & CEO, Mymee
Richard DeNunzio
Richard DeNunzio
SVP, Commercial at Click Therapeutics, Inc.
Featuring
Mette Dyhrberg
Mette Dyhrberg
Founder & CEO, Mymee
Richard DeNunzio
Richard DeNunzio
SVP, Commercial at Click Therapeutics, Inc.
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DTx Reimbursement in the US: Government-sponsored plans (Medicaid and Medicare)

30th August @ 10:45AM EDT

Are you a digital therapeutics (DTx) company seeking reimbursement in the US market? Join this masterclass led by the biopharma and DTx reimbursement expert Mike Pace to dive deeper into this topic.

Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Executive 1-2-1 with the HealthXL Digital Health Community

15th August @11AM EDT

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Featuring
Aahuti Rai
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Chris Wasden
Chris Wasden
Head of Pharma Speciality Solutions & Corporate Strategy, Twill
Featuring
Aahuti Rai
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Chris Wasden
Chris Wasden
Head of Pharma Speciality Solutions & Corporate Strategy, Twill
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sustainable Business Models for DTx

16th August @ 10:45AM EDT

It is one of the key questions that every digital therapeutic (DTx) company must answer - what business model will set them up for success in the long run? Join this meeting to discuss this further and share your experiences with your peers working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Payers Partnerships for DTx

17th August @ 10:45AM EDT

Digital Therapeutics (DTx) vendors face many challenges on their journey to commercialization, such as generating clinical data, health economics evidence and achieving regulatory status. Join this meeting to discuss this topic further and share your experiences with others working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology

Incentive Models for HCP & Care Team to Adopt Digital Health in Oncology

23rd August @ 10:45AM EDT

What are the best incentive models to encourage health care professionals (HCPs) and care teams to adopt digital health in oncology? Join this meeting to discuss this topic further with others working in this space.

Featuring
Susan Bratton
Susan Bratton
CEO & Founder at Savor Health
Ary Deleray
Ary Deleray
Personalized & Digital Health Strategy at Roche
Featuring
Susan Bratton
Susan Bratton
CEO & Founder at Savor Health
Ary Deleray
Ary Deleray
Personalized & Digital Health Strategy at Roche

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.